Cargando…
Plasma enhance drug sensitivity to bortezomib by inhibition of cyp1a1 in myeloma cells
BACKGROUND: Drug resistance is one of the major problems encountered in clinical therapy of multiple myeloma treatment. Combination treatment with several drugs may increase the sensitivity and overcome drug resistance. METHODS: Here, we combined chemotherapy with a newly developed technology, cold...
Autores principales: | Xu, Dehui, Cui, Qingjie, Xu, Yujing, Chen, Zeyu, Xia, Wenjie, Yang, Yanjie, Liu, Dingxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798238/ https://www.ncbi.nlm.nih.gov/pubmed/35117041 http://dx.doi.org/10.21037/tcr.2019.10.43 |
Ejemplares similares
-
Cold atmospheric plasma as a potential tool for multiple myeloma treatment
por: Xu, Dehui, et al.
Publicado: (2018) -
Alteration of metabolite profiling by cold atmospheric plasma treatment in human myeloma cells
por: Xu, Dehui, et al.
Publicado: (2018) -
Effect of He Plasma Jet Versus Surface Plasma on the Metabolites of Acute Myeloid Leukemia Cells
por: Xu, Dehui, et al.
Publicado: (2021) -
Effect of cold atmospheric plasma treatment on the metabolites of human leukemia cells
por: Xu, Dehui, et al.
Publicado: (2019) -
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
por: Zang, Meirong, et al.
Publicado: (2020)